Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03970616
Brief Title: A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma (DEDUCTIVE)

First Submitted : May 28, 2019
First Submitted that Met QC Criteria : May 30, 2019
First Posted : May 31, 2019

Last Update Submitted that Met QC Criteria : September 2, 2021
Last Update Posted : September 10, 2021